7) Ostermann M, et al : Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference : A Consensus Statement. JAMA Netw Open 3 : e2019209, 2020.
8) Prowle JR, et al : Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 10 : 37-47, 2014.
9) Kellum JA, et al : Acute kidney injury. Nat Rev Dis Primers 7 : 52, 2021.
10) Tumlin JA, et al : Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II. Crit Care Med 46 : 949-957, 2018.
11) Asfar P, et al : High versus low blood-pressure target in patients with septic shock. N Engl J Med 370 : 1583-1593, 2014.
13) Semler MW, et al : Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med 378 : 829-839, 2018.
14) STARRT-AKI Investigators, et al : Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med 383 : 240-251, 2020.
15) Gaudry S, et al : Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2) : a multicentre, open-label, randomised, controlled trial. Lancet 397 : 1293-1300, 2021.